SCHEMBL3335279

SCHEMBL3335279

NNc1cccc(-c2nncs2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 4/20 0.47
KDR P35968 3/20 0.47
CTSV O60911 1/20 0.36
CTSL P07711 1/20 0.36
CTSS P25774 1/20 0.36
CTSK P43235 1/20 0.36
LMNA P02545 2/20 0.33
NOS1 P29475 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
IDO1 P14902 1/20 0.33
CYP2C19 P33261 1/20 0.33
PTGS2 P35354 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MIF P14174 1/20 0.33
WNT1 P04628 1/20 0.33
GSK3B P49841 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11514694 0.75 CTSV (0.41) FGFR3KDRCTSVCTSLCTSS
SCHEMBL30442984 0.74 ALDH1A1 (0.53) LMNAIDO1ALDH1A1MEN1KMT2A
SCHEMBL31301193 0.74 KDM4E (0.53) TAAR1IDO1HSD17B1ALDH1A1MEN1
SCHEMBL5573502 0.74 HSD17B1 (0.61) LMNACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL31264268 0.74 NOTUM (0.46) IDO1KMT2APIM1SMN1; SMN2NPC1
SCHEMBL25488567 0.74 ALDH1A1 (0.53) LMNAIDO1ALDH1A1MEN1KMT2A
SCHEMBL572719 0.72 PDPK1 (0.45) CTSVCTSLCTSSCTSKTAAR1
SCHEMBL30610817 0.70 ALDH1A1 (0.51) LMNACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL1174898 0.70 TRIM24 (0.41) FGFR3KDRCTSVCTSLCTSS
SCHEMBL27757412 0.68 GOT1 (0.44) CTSVCTSLCTSSLMNANOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1868604-B1 REGULATION OF PROTEIN SYNTHESIS BY INHIBITION OF EIF4E-EIF4G INTERACTION HARVARD COLLEGE (US) 2014-08-13 EP disclosed
US-8257931-B2 Regulation of protein synthesis PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-09-04 US disclosed
US-20100144805-A1 Regulation of protein synthesis NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-06-10 US disclosed
EP-1868604-A2 REGULATION OF PROTEIN SYNTHESIS BY INHIBITION OF EIF4E-EIF4G INTERACTION PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2007-12-26 EP disclosed
WO-2006078942-A2 REGULATION OF PROTEIN SYNTHESIS BY INHIBITION OF EIF4E-EIF4G INTERACTION PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2006-07-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144805-A1 Regulation of protein synthesis EIF4EBP1, RNMT, NCBP1 FGFR3 4326/4885KDR 4629/4885CTSV 3095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.